Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06QER
|
|||
| Former ID |
DNC010425
|
|||
| Drug Name |
Benzaldehyde O-4-(nonyloxy)phenylcarbamoyl oxime
|
|||
| Synonyms |
CHEMBL597430; benzaldehyde O-4-(nonyloxy)phenylcarbamoyl oxime
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C23H30N2O3
|
|||
| Canonical SMILES |
CCCCCCCCCOC1=CC=C(C=C1)NC(=O)ON=CC2=CC=CC=C2
|
|||
| InChI |
1S/C23H30N2O3/c1-2-3-4-5-6-7-11-18-27-22-16-14-21(15-17-22)25-23(26)28-24-19-20-12-9-8-10-13-20/h8-10,12-17,19H,2-7,11,18H2,1H3,(H,25,26)/b24-19+
|
|||
| InChIKey |
GOOXRXVIMOMQCL-LYBHJNIJSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Oxime carbamate--discovery of a series of novel FAAH inhibitors. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1272-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.